Indapamida Teva (Indapamide)

Indapamide works by blocking the sodium‑chloride symporter located in the distal convoluted tubule of the kidney. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary loss of these ions along with water. The resulting drop in extracellular fluid volume lowers cardiac preload and systemic vascular resistance, helping to control blood pressure.

The appropriate dose of Indapamida Teva is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for indapamide in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider after evaluating the specific circumstances.

To request Indapamida Teva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class and shares many actions with traditional thiazides, such as promoting natriuresis. Compared with some thiazides, indapamide has a longer half‑life and may cause fewer metabolic disturbances, but individual response varies, and choice of therapy should be guided by clinical judgment.

Indapamida Teva should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct light, and store them out of reach of children.

Indapamida Teva is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include severe dehydration, electrolyte imbalances (especially low potassium), acute kidney injury, and rare allergic reactions such as rash or angioedema. Patients should be monitored for signs of these conditions and seek medical attention if they occur.

Indapamida Teva is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide diuretics, severe renal impairment, and in those who have experienced severe electrolyte disturbances that cannot be corrected. Clinicians should evaluate each patient’s medical history before prescribing.